Pharmanovia nelle notizie
Miglioramento dei farmaci per i pazienti
Tamtam ha trovato 13 articoli recenti su Pharmanovia.
- IMPACT Therapeutics licenses Senaparib to Pharmanovia
- Eupraxia Pharma Partners with Pharmanovia to License Senaparib in 66 Countries Including EU; Shares Surge Over 12%
- Pharmanovia licenses China-approved PARP drug for up to €423.5M
- IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib
- Pharmanovia Announces Launch of Korjuny (Catumaxomab) in Germany, a First-in-class Treatment for Malignant Ascites
- Brothers’ little helper: why are investors losing faith in Pharmanovia?
- Fitch Downgrades Pharmanovia to 'CCC+'
- Pharmanovia Seeks to Reassure Lenders as Performance Fears Grow
- Pharmanovia appoints Stephan Eder as CEO
- Pharmanovia Appoints Stephan Eder as Chief Executive Officer
- Pharmanovia Selects Honeywell’s Trackwise Digital® to Accelerate Pharmaceutical Quality
- PHARMANOVIA ACQUIRES GLOBAL CENTRAL NERVOUS SYSTEM (CNS) PORTFOLIO FROM SANOFI
- Stealth BioTherapeutics Enters into Exclusive Licensing Agreement with Pharmanovia to Commercialize Elamipretide for the Treatment of Barth Syndrome in Europe and Key Global Territories
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Pharmanovia?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili